News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Cognia Corporation Releases Cognia Molecular v1.6, An Innovative Biological Information Management Solution

10/19/2005 5:11:00 PM

NEW YORK--(BUSINESS WIRE)--April 22, 2004--Cognia announced today the release of a powerful information management system, Cognia Molecular(TM) v1.6. Cognia Molecular, the result of five year's evolutionary research and development, enables industry and academic users alike to integrate, manage, and utilize biological and chemical information from many formats and sources in support of drug discovery and basic research. Cognia Molecular can be augmented with Cognia's value-added content products and services, as well as many datasets and systems its customers may already be using.

Cognia's business/product model was developed through experience and use with over one hundred Pharmaceutical, Biotechnology and Research Centers. This experience confirmed that all sectors of the industry are overwhelmed by the increasingly fast growing wave of public and proprietary research data available. This information exists in numerous disparate locations, utilizes a wide array of formats, nomenclature and identifiers and is erratically accessible. Researchers are finding it increasingly difficult to find and manage this information -- let alone use it effectively. Cognia Molecular was developed to meet these challenges.

"The unmet need for solutions that help researchers manage and share critical information is really incredible at Biotechs, Pharmas, and in academia," said John Chiplin, Ph.D., Cognia's Chairman. "With Cognia Molecular, researchers can now easily centralize relevant information and make sense of their findings in the context of what is already known."

Cognia Molecular enables researchers to integrate their own proprietary information with that from outside sources, making both centralized and easily accessible. Cognia Molecular's user-friendly curation clients, powerful automated batch-loading tools, and links to over thirty-five external databases enable researchers to effectively centralize disparate internal and external information. This makes it easy for researchers to input findings into Cognia Molecular utilizing tools such as, FlexLoader(TM) an innovative application that allows users to formulate their own solutions to information entry and retrieval, and InteractionLoader(TM), a batch loading application to expedite bulk upload of interaction information. Cognia also includes many parsed and curated datasets to provide a powerful working framework of content.

Because of Cognia Molecular's highly organized relational database architecture that utilizes controlled vocabularies and standard nomenclatures, the integrated information is amenable for analyses with tools such as an integrated complex querying engine and NetworkBuilder(TM). Using our well-documented API users can configure and connect their own analysis applications to exploit the content housed within Cognia Molecular.

Licenses for Cognia Molecular and related services can be tailored to meet the specific requirements of most organizations. Please contact Cognia's sales team at or 212-331-7842 for additional information.

About Cognia

Cognia Corporation is a developer of information products and services that facilitate the integration, management, and utilization of biological and chemical information. Cognia's information solutions enable pharmaceutical and biotechnology companies to cost-effectively discover and develop new drugs by accelerating research processes. The Cognia Molecular (TM) information management system supports drug discovery efforts in a wide range of disease areas and cellular processes. The development of Cognia Molecular is the result of managing customer relationships with more than one hundred Pharmaceutical, Biotechnology and Research Centers such as Merck & Co., GlaxoSmithKline, Aventis, Schering-Plough Research Institute and learning first-hand about their needs. Cognia distributes life sciences and chemical databases from John Wiley & Sons and are the exclusive North American distributors of the TRANSFAC(R) and TRANSPATH(R) Professional gene regulation databases by BIOBASE GmbH.


Cognia Corporation Nadine Santiago, 212-331-7849

Read at

comments powered by Disqus